MYCN and neuroblastoma: The independence of the miRNA differentiation-inducing functions from the oncogenic function of MYCN supports the general therapeutic potential of these miRNAs — the miRNAs induce cell differentiation regardless of MYCN expression status in the neuroblastoma cells, and they therefore can be potentially used to treat both MYCN-amplified and MYCN-nonamplified neuroblastomas.